About Us

Finding new & better treatments for Type 1 Diabetes

Who We Are

The Type 1 Diabetes UK Immunotherapy Consortium (T1D UK) was set up in 2015 with major funding from Diabetes UK & the JDRF, to promote, develop and support immunotherapy research in T1D.

T1D UK has established a network of 24 Research Sites strategically distributed across the UK to recruit children and adults into clinical trials of new immunotherapy treatments in T1D

There are 2 main cores to T1D UK, a clinical engagement & training core (CET) led by Prof Colin Dayan from Cardiff University and a mechanistic core of 5 specialist Labs located throughout the UK, led by Tim Tree from Kings College, London.

Our Partners

Principal Aim

To help get immune therapy into the market as part of the management for type 1 diabetes.

The Vision

An improved environment for immune therapy trials in the UK: rapid, early and enhanced patient recruitment; enhanced academic engagement with trial design; the provision of a mechanistic core.

The Clinical Engagement & Training Core

The aim of the CET team is to support recruitment into immune therapy trials. The team will co-ordinate and promote trials to Research Sites, engage with teams at the sites and develop and deliver a training programme for research and clinical teams at sites.

Mechanistic Core

The mechanistic core brings together experts in the immunology of T1D from 5 different labs across the UK: Bristol, Cardiff, Oxford, King’s College London, & Queen Mary’s London. These laboratories will provide state of the art immunological assays that will study the impact of immune therapy trials, investigating exactly how different treatments work to control the immune attack that causes type 1 diabetes and working out if it is possible to predict who will benefit from each treatment.

Immunotherapy Treatment for Type 1 Diabetes

Colin Dayan explains immunotherapy for T1D – here interviewed by Vivienne Parry OBE prior to a plenary lecture at the EASD in Berlin Sept 2018.

Twitter Feeds

T1DUKFollow

Research to find new and better treatment for Type 1 Diabetes.

JDRF UK@JDRFUK·

28 Jan

.@T1D_UK is looking for people with #type1 #diabetes to take part in a survey on research. Children & adults with #type1 & also parents/ family - get involved in helping to shape #type1 clinical trials so more people with #T1D take part! Learn more: https://jdrf.org.uk/our-research/how-you-can-get-involved/projects-you-can-join/ #GBDoc https://twitter.com/DUK_research/status/1221882092214030336

Cookie and Privacy Settings

How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Click to enable/disable google analytics tracking.

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Click to enable/disable google webfonts.

Google Map Settings:

Click to enable/disable google maps.

Vimeo and Youtube video embeds:

Click to enable/disable video embeds.